FDA-AstraZeneca Hearing
Netracor J & J heart Drug May Raise Risk of Dying Wed, 20 Apr 2005 A new research challenges the safety level linked with the drug ‘Natretor.’ Scios Inc., a subsidiary of Johnson & Johnson is the maker of “Natrecor.” “Researchers say that the use of heart-failure drug Natrecor results…
UK Health Dept/ British Prime Minister/ Issue Statement Warning No PAXIl for Children! Tue, 10 Jun 2003 UK GOVERNMENT STATEMENT: Press release: reference 2003/0223 Tuesday 10th June 2003 Related Story: GlaxoSmithKline discloses link to serious undesirable effects in depressed children and adolescents under age 18 SEROXAT MUST NOT BE USED…
A critical examination of meta-analysis studies by John H. Noble, Jr, Ph.D, AHRP Treasurer
Conflicts of Interest policy – New York Times Sun, 28 Mar 2004 To: ‘Executive-editor@nytimes’; ‘gcollins@nytimes’; ‘arosenthal@nytimes’; ‘pboffey@nytimes’; ‘lchang@nytimes’; ‘oped@nytimes’ Cc: ‘Daniel Okrent’ ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting openness and full disclosure https://ahrp.org FYI Friday’s New York Times included the following Editor’s Note on the paper’s Op Ed page:…
Dissenting Opinion (NHRPAC Children Workgroup) re: Proposed Reinterpretation of Fed. Regs Protecting Children (45 CFR 46, sections 404 and 406) May 14, 2002 To: Alan Fleischman, MD, Chair, Children’s Workgroup of NARPAC Mary Faith Marshall, Ph.D., Chair, NARPAC From: Vera Hassner Sharav Re: Dissenting Opinion re: Report to NHRPAC, proposing…
"Does this appointment signify that Harvard Medical School intends to even further strengthen its research ties to the pharmaceutical industry?"